Cargando…
Tumor‐Activatable Nanoparticles Target Low‐Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy
The binding of plasma proteins to nanomedicines is widely considered detrimental to their delivery to tumors. Here, the design of OxPt/SN38 nanoparticle containing a hydrophilic oxaliplatin (OxPt) prodrug in a coordination polymer core and a hydrophobic cholesterol‐conjugated SN38 prodrug on the lip...
Autores principales: | Jiang, Xiaomin, Han, Wenbo, Liu, Jianqiao, Mao, Jianming, Lee, Morten J., Rodriguez, Megan, Li, Youyou, Luo, Taokun, Xu, Ziwan, Yang, Kaiting, Bissonnette, Marc, Weichselbaum, Ralph R., Lin, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404402/ https://www.ncbi.nlm.nih.gov/pubmed/35748191 http://dx.doi.org/10.1002/advs.202201614 |
Ejemplares similares
-
Nanoscale
Metal–Organic Framework Confines
Zinc-Phthalocyanine Photosensitizers for Enhanced Photodynamic Therapy
por: Luo, Taokun, et al.
Publicado: (2021) -
Nanoscale Metal–Organic
Framework with an X-ray
Triggerable Prodrug for Synergistic Radiotherapy and Chemotherapy
por: Xu, Ziwan, et al.
Publicado: (2023) -
Two-Stage
SN38 Release from a Core–Shell Nanoparticle
Enhances Tumor Deposition and Antitumor Efficacy for Synergistic Combination
with Immune Checkpoint Blockade
por: Jiang, Xiaomin, et al.
Publicado: (2022) -
A self-assembled nanophotosensitizer targets lysosomes and induces lysosomal membrane permeabilization to enhance photodynamic therapy
por: Li, Youyou, et al.
Publicado: (2023) -
Red-Light-Activatable AND-Gated Antitumor Immunosuppressant
por: Zhou, Ziqi, et al.
Publicado: (2023)